Predictive testing for Huntington’s disease (HD) has been available for individuals at risk of HD by direct mutation analysis since 1993. International Predictive test guidelines recommend that support is offered following the result regardless of test outcome. However, there is lack of an evidence base regarding what this support should look like and how it might work in practice.
Objective:
A service improvement initiative looked at the feasibility of offering a narrative group session co-facilitated by a genetic counsellor and clinical psychologist, to individuals who had tested mutation negative for HD. The narrative session was evaluated from the perspective of group participants.
Methods:
Individuals who tested mutation negative at a genetic centre in the North of England over a 5-year period were invited to attend a narrative group session. 52 people were contacted and 9 people agreed to participate. Participants completed standardised questionnaires (PHQ-9 and GAD-7) before and after the session and a detailed written evaluation. Participants’ comments were analysed thematically.
Results:
Participants were overwhelmingly positive about the narrative session finding it a safe and enjoyable way to explore difficult life experiences. Reported benefits included feeling less isolated, being inspired by other people’s stories and connecting as a group. All 9 participants said they would recommend the narrative session to anyone impacted by HD.
Conclusions:
The narrative group session was considered an interesting and useful approach to facilitating adaptation following a negative predictive test result for HD.
CraufurdD, MacLeodR, FrontaliM, QuarrellO, BijlsmaEK, DavisM, et al. Diagnostic genetic testing for Huntington’s disease. Pract Neurol. 2015;15(1):80–4.
2.
The Huntington’s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell. 1993;72(6):971–83.
3.
World Federation of Neurology: Research Committee. Research Group on Huntington’s chorea. Ethical issues policy statement on Huntington’s disease molecular genetics predictive test. J Neurol Sci. 1989;94(1-3):327–32.
4.
WentL. Ethical issues policy statement on Huntington’s disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology. J Med Genet. 1990;27(1):34–8.
5.
International Huntington Association and the World Federation of Neurology Research Group on Huntington’s Chorea. Guidelines for the molecular genetics predictive test in Huntington’s disease. J Med Genet. 1994;31(7):555–9.
6.
MacLeodR, TibbenA, FrontaliM, Evers-KieboomsG, JonesA, Martinez-DescalesA, et al. Recommendations for the predictive genetic test in Huntington’s disease. Clin Genet. 2013;83(3):221–31.
7.
ShawC, AbramsK, MarteauTM. Psychological impact of predicting individuals’ risks of illness: A systematic review. Social Sci Med. 1999;49(12):1571–98.
8.
SilverA. Cognitive-behavioural therapy with a Huntington’s gene positive patient. Patient Educ Couns. 2003;49(2):133–8.
9.
BonelliRM, WenningGK, KapfhammerHP. Huntington’s disease: Present treatments and future therapeutic modalities. Int Clin Psychopharmacol. 2004;19(2):51–62.
10.
SobelS. Thursdays with Marion: The Therapist’s Tale. J Genet Counsel. 2005;14(5):341–7.
11.
KloosAD, FritzNE, KostykSK, YoungGS, KegelmeyerDA. Video game play (Dance Dance Revolution) as a potential exercise therapy in Huntington’s disease: A controlled clinical trial. Clin Rehabil. 2013;27(11):972–82.
12.
MorganA. What is Narrative Therapy? An easy to read introduction. 2000: Dulwich Centre Publications.
13.
National Society of Genetic Counsellors’ Definition Task Force. A new definition of Genetic Counselling: National Society of Genetic Counsellors’ Task Force report. J Genet Couns. 2006;15(2):77–83.
14.
Socio-Psychological Research in Genomics (SPinG collaboration). Developing an intervention to facilitate family communication about inherited genetic conditions and training genetic counsellors in its delivery. Eur J Hum Genet. 2016;24(6):794–802.
15.
LopesRT, GonçalvesMM, FassnachtDB, MachadoPP, SousaI. Long-term effects of psychotherapy on moderate depression: A comparative study of narrative therapy and cognitive-behavioral therapy. J Affect Disord. 2014;167:64–73.
16.
SeoM, KangHS, LeeYJ, ChaeSM. Narrative therapy with an emotional approach for people with depression: Improved symptom and cognitive-emotional outcomes. J Psychiatr Ment Health Nurs. 2015;22(6):379–89.
17.
GwozdziewyczN, Mehl-MadronaL. Meta-analysis of the use of narrative exposure therapy for the effects of trauma among refugee populations. Perm J. 2013;17(1):70–6.
18.
RobjantK, FazelM. The emerging evidence for narrative exposure therapy: A review. Clin Psychol Rev. 2010;30(8):1030–9.
19.
ErbesCR, StillmanJR, WielingE, BeraW, LeskelaJ. A pilot examination of the use of narrative therapy with individuals diagnosed with PTSD. J Trauma Stress. 2014;27(6):730–3.
20.
KnightKM, BundyC, MorrisR, HiggsJF, JamesonRA, UnsworthP, et al. The effects of group motivational interviewing and externalizing conversations for adolescents with Type-1 diabetes. Psychol Health Med. 2003;8(2):149–57.
21.
WeberM, DavisK, McPhieL. Narrative therapy, eating disorders and groups: Enhancing outcomes in rural NSW. Aust Soc Work. 2006;59(4):391–405.
22.
EeltinkC, DuffyM. Restorying the illness experience in multiple sclerosis. Fam J. 2004;12(3):282–6.
23.
GriffithJL, GriffithME. The body speaks: Therapeutic dialogues for mind-body problems. Basic Books; 1994.
24.
VegaP, RiveraMS, GonzálezR. When grief turns into love understanding the experience of parents who have revived after losing a child due to cancer. J Pediatr Oncol Nurs. 2014;31(3):166–76.
25.
WeingartenK. Cancer, meaning-making and hope: The Treatment Dedication Project. Fam Syst Health. 2004;(22):151–7.
26.
NgC. Consulting young people about living with cancer. Int J Narrat Ther Community Work. 2015;2:51–7.
27.
HedtkeL. Creating stories of hope: A narrative approach to illness, death and grief. Aust N Z J Fam Ther. 2014;35(1):4–19.
28.
QuirogaA, JiménezJV, BeltránGA, CasasV, LópezBN. A narrative approach to addressing pain in hospitalised paediatric patients: Handicraft and digital interventions. Int J Narrat Ther Community Work. 2016;(4):77–85.
29.
BrownA, BruceD, BerryR. How do you write pain? A preliminary study of narrative therapy for people with chronic pain. Divers Health Care. 2010;7(1):43–56.
30.
ChenailRJ, GeorgeSS, WulffD, DuffyM, ScottKW, TommK. Clients’ relational conceptions of conjoint couple and family therapy quality: A grounded formal theory. J Marital Fam Ther. 2012;38(1):241–64.
31.
VromansLP, SchweitzerRD. Narrative therapy for adults with major depressive disorder: Improved symptom and interpersonal outcomes. Psychother Res. 2011;21(1):4–15.
AlmqvistEW, BrinkmanRR, WigginsSU, HaydenMR. Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington’s disease. Clin Genet. 2003;64(4):300–9.
34.
BroadstockM, MichieS, MarteauM. Psychological consequences of predictive genetic testing: A systematic review. Eur J Hum Genet. 2000;8(10):731–8.
35.
DuisterhofM, TrjisburgRW, NiermeijerMF, RoosTA, TibbenA. Psychological studies in Huntington’s disease: Making up the balance. J Med Genet. 2001;38(12):852–61.
36.
CrozierS, RobertsonN, DaleM. The psychological impact of predictive genetic testing for Huntington’s disease: A systematic review of the literature. J Genet Couns. 2015;24(1):29–39.
37.
TimmanR, RoosR, Maat-KievitA, TibbenA. Adverse effects of predictive testing for Huntington disease underestimated: Long-term effects 7-10 years after the test. Health Psychol. 2004;23(2):189–97.
38.
HugginsM, BlochM, WigginsS, AdamS, SuchowerskyO, TrewM, et al. Predictive testing for Huntington disease in Canada: Adverse effects and unexpected results in those receiving a decreased risk. Am J Med Genet. 1992;42(4):508–15.
39.
GargiuloM, LejeuneS, TanguyML, Lahlou-LaforêtK, FaudetA, CohenD, et al. Long-term outcome of presymptomatic testing in Huntington disease. Eur J Hum Genet. 2009;17(2):165.
40.
WhiteM, EpstonD. Narrative means to therapeutic ends. WW Norton & Company; 1990.
41.
WhiteM. Working with people who are suffering the consequences of multiple trauma: A narrative perspective. Int J Narrat Ther Community Work. 2004;(1):45.
42.
Ncube-MilloN, DenboroughD. Tree of Life, mainstreaming psychosocial care and support: A manual for facilitators. 2007, Randburg, South Africa: REPSSI.
43.
HughesG. Finding a voice through ‘The Tree of Life’: A strength-based approach to mental health for refugee children and families in schools. Clin Child Psychol Psychiatry. 2014;19(1):139–53.
44.
KroenkeK, SpitzerRL, WilliamsJB. The PHQ- Validity of a brief depression severity measure. Gen Intern Med. 2001;16:606–13.
45.
SpitzerRL, KroenkeK, WilliamsJB, LöweB. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med. 2006;166(10):1092–7.
46.
PopeC, MaysN, editors. Qualitative research in healthcare. 3rd edition. Blackwell Publishing Ltd: 2006.
47.
KroenkeK, SpitzerRL, WilliamsJBW, LöweB. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: A systematic review. Gen Hosp Psychiatry. 2010;32:345–59.
48.
ManeaL, GilbodyS, McMillanD. A diagnostic meta-analysis of the Patient Health Questionnaire-9 (PHQ-9) algorithm scoring method as a screen for depression. Gen Hosp Psychiatry. 2015;37:67–75.
49.
McAllisterM, PayneK, MacLeodR, NichollsS, DonnaiD, DaviesL. Patient empowerment in clinical genetics services. J Health Psychol. 2008;13(7):895–90.
50.
McAllisterM, WoodAM, DunnG, ShilohS, ToddC. The Genetic Counselling Outcome Scale: A new patient-reported outcome measure for clinical genetics services. Clin Genet. 2011;79(5):413–24.
